Rena Marie Conti : Citation Profile


Boston University

5

H index

3

i10 index

96

Citations

RESEARCH PRODUCTION:

9

Articles

12

Papers

3

Chapters

RESEARCH ACTIVITY:

   19 years (2006 - 2025). See details.
   Cites by year: 5
   Journals where Rena Marie Conti has often published
   Relations with other researchers
   Recent citing documents: 16.    Total self citations: 2 (2.04 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pco1176
   Updated: 2025-12-20    RAS profile: 2025-06-27    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Gruber, Jonathan (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Rena Marie Conti.

Is cited by:

Dunn, Abe (3)

Philipson, Tomas (3)

Dubois, Pierre (3)

Behncke, Stefanie (3)

Ridley, David (2)

boone, jan (2)

Jaffe, Sonia (2)

Gamba, Simona (2)

Vella, Francis (2)

Florio, Massimo (2)

Skinner, Jonathan (2)

Cites to:

Gaynor, Martin (3)

Vogt, William (3)

Newhouse, Joseph (2)

Salkever, David (2)

Cockburn, Iain (2)

Ridley, David (2)

Yurukoglu, Ali (2)

Liebman, Eli (2)

Schmalensee, Richard (2)

Waidmann, Timothy (1)

Blau, David (1)

Main data


Where Rena Marie Conti has published?


Journals with more than one article published# docs
Journal of Policy Analysis and Management2
Journal of Economic Perspectives2
PharmacoEconomics2

Working Papers Series with more than one paper published# docs
NBER Working Papers / National Bureau of Economic Research, Inc12

Recent works citing Rena Marie Conti (2025 and 2024)


YearTitle of citing document
2024How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?. (2024). Dafny, Leemore ; Ho, Kate ; Kong, Edward. In: American Economic Journal: Economic Policy. RePEc:aea:aejpol:v:16:y:2024:i:3:p:314-46.

Full description at Econpapers || Download paper

2025Who Pays, Who Benefits? Producer-Insurer Games in Life-Saving Medicines. (2025). Leh, Thomas ; Coculescu, Delia ; Janisch, Maximilian. In: Papers. RePEc:arx:papers:2509.16125.

Full description at Econpapers || Download paper

2025Effect of Market Entry on Generic Drug Prices: Medicare Data 2007-2022. (2025). Buchmueller, Thomas ; Zuckerman, Rachael ; Bosworth, Arielle ; Sheingold, Steven ; Nguyen, Nguyen Xuan. In: International Journal of Research and Innovation in Social Science. RePEc:bcp:journl:v:9:y:2025:i:1:p:1485-1496.

Full description at Econpapers || Download paper

2024Relative size distribution of business firms—A QRSE approach. (2024). Sundal, Douhan. In: Economic Modelling. RePEc:eee:ecmode:v:140:y:2024:i:c:s0264999324002049.

Full description at Econpapers || Download paper

2025Price regulation and competition among on-patent anticancer drugs in Italy. (2025). Mancusi, Maria ; Vassallo, Chiara ; Fiorentino, Francesca ; di Costanzo, Alessandra ; Candelora, Laura ; Caimmi, Michele ; Canali, Beatrice. In: Health Policy. RePEc:eee:hepoli:v:157:y:2025:i:c:s0168851025001046.

Full description at Econpapers || Download paper

2024Public entry and private prices: New evidence from Indian pharmaceutical markets. (2024). Gupta, Samarth ; Chatterjee, Chirantan. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:219:y:2024:i:c:p:473-489.

Full description at Econpapers || Download paper

2025Procurement institutions and essential drug supply in low and middle-income countries. (2025). Zahur, Nahim Bin ; Wang, Lucy Xiaolu. In: Journal of Health Economics. RePEc:eee:jhecon:v:101:y:2025:i:c:s016762962500030x.

Full description at Econpapers || Download paper

2024Pricing above value: Selling to a market with selection problems. (2024). Boone, Jan. In: Journal of Health Economics. RePEc:eee:jhecon:v:94:y:2024:i:c:s0167629624000134.

Full description at Econpapers || Download paper

2025Strategic buyer stockpiling in supply chains under uncertain product availability and price fluctuation. (2025). Yan, Xue ; Jin, Shibo ; He, Yong ; Li, Shanshan. In: Omega. RePEc:eee:jomega:v:133:y:2025:i:c:s030504832500009x.

Full description at Econpapers || Download paper

2025Nothing for something: Marketing cancer drugs to physicians increases prescribing without improving mortality. (2025). Li, Jing ; Daly, Michael ; Carey, Colleen. In: Journal of Public Economics. RePEc:eee:pubeco:v:242:y:2025:i:c:s004727272500009x.

Full description at Econpapers || Download paper

2025The value of group purchasing: Evidence from the U.S. hospital industry. (2025). Wang, Yanhao ; Lin, Haizhen. In: Journal of Public Economics. RePEc:eee:pubeco:v:247:y:2025:i:c:s0047272725000787.

Full description at Econpapers || Download paper

2024Competition, value-based prices and incentives to research personalised drugs. (2024). LEVAGGI, ROSELLA. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:93:y:2024:i:c:s0038012124000697.

Full description at Econpapers || Download paper

2024Profits over care? An analysis of the relationship between corporate capitalism in the healthcare industry and cancer mortality in the United States. (2024). Perry, Teresa ; Bernasek, Alexandra. In: Social Science & Medicine. RePEc:eee:socmed:v:349:y:2024:i:c:s0277953624002958.

Full description at Econpapers || Download paper

2025Navigating payment and policy barriers to gender-affirming care for transmasculine individuals: A qualitative study and policy assessment. (2025). Grov, Christian ; Zewde, Naomi ; D'Angelo, Alexa B ; Dearolf, Michelle ; Restar, Arjee ; Tsui, Emma K. In: Social Science & Medicine. RePEc:eee:socmed:v:366:y:2025:i:c:s0277953624011201.

Full description at Econpapers || Download paper

2024Price negotiation and pricing of anticancer drugs in China: An observational study. (2024). Pan, Jay ; Lu, Hao ; Lan, Tianjiao ; Zhou, Jing. In: PLOS Medicine. RePEc:plo:pmed00:1004332.

Full description at Econpapers || Download paper

2025Pharmaceutical Regulation and Incentives for Innovation in an International Perspective. (2025). Dubois, Pierre. In: TSE Working Papers. RePEc:tse:wpaper:131002.

Full description at Econpapers || Download paper

Works by Rena Marie Conti:


YearTitleTypeCited
2015Pricing in the Market for Anticancer Drugs In: Journal of Economic Perspectives.
[Full Text][Citation analysis]
article46
2015Pricing in the Market for Anticancer Drugs.(2015) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 46
paper
2025The Economics of Generic Drug Shortages: The Limits of Competition In: Journal of Economic Perspectives.
[Full Text][Citation analysis]
article1
2012How do Initial Signals of Quality Influence the Diffusion of New Medical Products? The Case of New Cancer Drug Treatments In: Advances in Health Economics and Health Services Research.
[Full Text][Citation analysis]
chapter0
2024Stockpiling at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices In: Management Science.
[Full Text][Citation analysis]
article1
2009Early Retirement and DI/SSI Applications: Exploring the Impact of Depression In: NBER Chapters.
[Full Text][Citation analysis]
chapter0
2016Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001–2007 In: NBER Chapters.
[Full Text][Citation analysis]
chapter6
2014Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007.(2014) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 6
paper
2006Early Retirement and Public Disability Insurance Applications: Exploring the Impact of Depression In: NBER Working Papers.
[Full Text][Citation analysis]
paper12
2011The Effect of FDA Advisories on Branded Pharmaceutical Firms Valuations and Promotion Efforts In: NBER Working Papers.
[Full Text][Citation analysis]
paper1
2017The Landscape of US Generic Prescription Drug Markets, 2004-2016 In: NBER Working Papers.
[Full Text][Citation analysis]
paper11
2017The Generic Drug User Fee Amendments: An Economic Perspective In: NBER Working Papers.
[Full Text][Citation analysis]
paper1
2019Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets In: NBER Working Papers.
[Full Text][Citation analysis]
paper5
2020Four Facts Concerning Competition in US Generic Prescription Drug Markets.(2020) In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 5
article
2019The Surprising Hybrid Pedigree of Measures of Diversity and Economic Concentration In: NBER Working Papers.
[Full Text][Citation analysis]
paper2
2019The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications In: NBER Working Papers.
[Full Text][Citation analysis]
paper1
2020Valuing Rare Pediatric Drugs: An Economics Perspective In: NBER Working Papers.
[Full Text][Citation analysis]
paper2
2021Estimating the Financial Impact of Gene Therapy in the U.S. In: NBER Working Papers.
[Full Text][Citation analysis]
paper1
2021Common Agent or Double Agent? Pharmacy Benefit Managers in the Prescription Drug Market In: NBER Working Papers.
[Full Text][Citation analysis]
paper2
2010Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities In: Medical Decision Making.
[Full Text][Citation analysis]
article4
2020Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2020Reply to Comment on “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US” In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2016THE ADVANTAGES OF AWARDING THE FEDERAL GOVERNMENT NEGOTIATING POWER OVER THE PRICES OF PRESCRIPTION DRUGS In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article0
2016RESPONSE TO JOYCE AND SOOD In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 20 2025. Contact: CitEc Team